The antihyperlipidemic effect of a standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea ) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patie

Hermans, Michel;Dierckxsens, Yvan;Janssens, Isabelle;Seidel, Laurence;Khan, Amjad;et.al.
(2023) Frontiers in Pharmacology — Vol. 14, p. 1280234 [1-13] (2023)

Files

2023_Hermans_Front_Pharmacol.pdf
  • Open Access
  • Adobe PDF
  • 1.12 MB
Download

Details

Authors
  • Hermans, MichelUCLouvain
    Author
  • Dierckxsens, Yvan
    Author
  • Janssens, Isabelle
    Author
  • Seidel, Laurence
    Author
  • Ahn, Sylvie A.UCLouvain
    Author
  • Rousseau, MichelUCLouvain
    Author
  • Khan, Amjad
    Author
Show more
Abstract
Hyperlipidemia is associated with a higher rate of cardiovascular, cerebrovascular, and peripheral vascular disease. Conventional drugs such as statins are effective in controlling hyperlipidemia, but are associated with various side-effects, especially myalgia. Nutraceutical lipid-lowering interventions are becoming increasingly popular, particularly among patients who are intolerant or refractory to statins. Substantial preclinical and clinical evidence suggests that amla, walnut, and olive extracts and red yeast rice (RYR) powder possess significant antihyperlipidemic effects.This study aimed to evaluate the efficacy, safety, and patient's satisfaction of a combined supplementation of standardized dry extracts of amla fruit (500 mg), walnut leaves (50 mg), olive fruit (25 mg) and RYR powder (33.6 mg) (Cholesfytol NG ® ) in hypercholesterolemic patients. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hermans, M., Dierckxsens, Y., Janssens, I., Seidel, L., Adelin Albert, Ahn, S. A., Rousseau, M., & Khan, A. (2023). The antihyperlipidemic effect of a standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea ) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patie. Frontiers in Pharmacology, 14, 1280234 [1-13]. https://doi.org/10.3389/fphar.2023.1280234 (Original work published 2023)